S&P 500
+17.60 +0.87%
Dow Indu
+138.46 +0.81%
+17.99 +0.37%
Crude Oil
+1.04 +2.09%
+10.565 +0.92%
+0.00617 +0.55%
US Dollar
-0.383 -0.49%

New York Mercantile ExchangeCOPPER Dec 2015 (E) (NYMEX:HG.Z15.E)

2.4290 +0.0860 (+3.66%)

2015-10-09 06:14:55, 30 min delay

COPPER Dec 2015 (E) (NYMEX:HG.Z15.E) Future Chart
1 Day
3 Day
5 Day
1 Month
3 Month
6 Month
1 Year
Last Price2.4290
Settle Time13:14
Previous Close2.3505
Open Int.98750
Contract High4.1705
Contract Low2.2025
Estimated Volume45058
Close Time13:00
Net Change0.0860
Time2015-10-09 06:14:55
Contract High Date2011-07-19
Contract Low Date2015-08-24
First Delivery2015-12-31
Open Time08:10

Free Instant Analysis: Let our Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly analyze any stock, futures or forex market for you. It’s free, It’s informative, It’s on the money. View our complimentary trend analysis for COPPER Dec 2015 (E) (HG.Z15.E) now.

First Name
Last Name

By filling out the form, you'll receive access to trend analysis, educational videos, and other trading resources from INO.com. Trend Analysis will be sent directly to your inbox.

Trader's Blog

3 Stocks That Could Win Big In The Fourth Quarter
   18 hours ago
How to Profit from Government Mandates in Biofuels
   21 hours ago
Ride The Oil Recovery With This Driller
   1 day ago

Today's Financial News

Average US rate on 30-year mortgages falls to 3.76 percent; 15-year loan down to 2.99 percent

14 hours ago

WASHINGTON (AP) — Average long-term U.S. mortgage rates fell sharply this week amid concern over a labor market that has shown recent signs of weakness. Rates have stayed below 4 percent for 11 straight weeks. This week's decline brought rates to levels far below last year's levels, providing an inducement for potential homebuyers. A year ago, the average 30-year mortgage rate was 4.19 percent, while the rate for 15-year loans was 3.36 percent.

Drug developer Genentech says multiple sclerosis treatment worked in 3 studies

14 hours ago

NEW YORK (AP) — Genentech released the results Thursday of three late-stage studies of a multiple sclerosis treatment that showed improved symptoms in patients compared with an established treatment. In two studies that lasted two years, relapsing M.S. patients showed less flare ups, a reduction of brain lesions and improvement of other symptoms when taking ocrelizumab, which is given intravenously every six months, when compared to a current M.S. treatment on the market called Rebif, which is injected three times per week. Rebif is made by Pfizer Inc. and Merck KGaA's subsidiary EMD Serono Inc.

Ex-Bellagio craps dealer's guilty plea reset in $1M Las Vegas Strip bet cheating case

14 hours ago

LAS VEGAS (AP) — A judge postponed until Tuesday an ex-dealer's guilty plea in an agreement that will have him testify against three co-defendants accused of cheating a Las Vegas Strip casino out of more than at $1 million in craps bets. Cooper is expected to plead guilty to theft and face one-to-five years in prison.

Protesters, supporters pack meeting of agency eyeing plan to expand whale tanks at SeaWorld

15 hours ago

LONG BEACH, Calif. (AP) — Protesters and supporters filled a meeting room Thursday where a California commission was considering a vast expansion to the tanks that SeaWorld uses to hold killer whales in San Diego. The 500 people who packed the meeting room included SeaWorld supporters wearing blue and white shirts and holding signs saying, "Educate, Inspire, Conserve," and critics waving signs saying "Vote no on SeaWorld Tanks" and "SeaWorld hurts Orcas."

INO.com on Facebook INO.com MarketClub on Twitter INO.com on Google+ INO.com YouTube

© Copyright INO.com, Inc. All Rights Reserved.